ADE (chemotherapy)
ADE (chemotherapy)
ADE is a chemotherapy regimen for treatment of acute myeloid leukemia (AML). It is an acronym for three drugs used in the treatment: Cytarabine (also known as ARA-C), Daunorubicin (also known as Daunomycin), and Etoposide.
Treatment Regimen[edit]
The ADE chemotherapy regimen is typically administered in a hospital setting due to the intensive nature of the treatment. The regimen is usually given in cycles, with each cycle lasting about a week. The specific dosage and schedule may vary depending on the patient's overall health and specific type of AML.
Cytarabine[edit]
Cytarabine, or ARA-C, is a chemotherapy drug that works by slowing or stopping the growth of cancer cells. It is given by injection into a vein or under the skin.
Daunorubicin[edit]
Daunorubicin, or Daunomycin, is a chemotherapy drug that works by stopping the growth of cancer cells. It is given by injection into a vein.
Etoposide[edit]
Etoposide is a chemotherapy drug that works by stopping the growth of cancer cells. It is given by injection into a vein.
Side Effects[edit]
Like all chemotherapy regimens, ADE can cause side effects. These may include nausea, vomiting, hair loss, and fatigue. More serious side effects can include infection, bleeding, and anemia. Patients should discuss potential side effects with their healthcare provider before starting treatment.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
